Total Funding
81
61
Total FundingPost-IPO Equity raised
Growth Score
-10 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9534
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
- Gerald Horn: Founder & Senior Scientific Advisor
- James McCollum: Co-FounderPast Role: LENZ Therapeutics, President and Chief Executive Officer.
About the Company
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes. Its program is an aceclidine-based eye drop designed to restore the loss of near vision associated with presbyopia.
